Filed: 5/15/2025ACC: 0000905148-25-001748
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $123.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$123.56M
Total AUM (reported)
29.37M
Total Shares
Allocation by class
COM$123.56M100.0%
Portfolio Concentration
Top 3$100.69M81.5%
4–10$22.86M18.5%
Top 3 weight
81.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 29.37M
Sole
Full voting authority
29.37M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
PHARVARIS N V
SOLEShares4.29M
TypeSH
Market value$67.34M
54.50%
Sole
4.29M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares2.79M
TypeSH
Market value$17.11M
13.85%
Sole
2.79M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares489.19K
TypeSH
Market value$16.24M
13.14%
Sole
489.19K
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares3.81M
TypeSH
Market value$9.40M
7.61%
Sole
3.81M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$6.04M
4.89%
Sole
9.70M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares7.10M
TypeSH
Market value$3.82M
3.09%
Sole
7.10M
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares1.20M
TypeSH
Market value$3.60M
2.91%
Sole
1.20M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHARVARIS N VSOLE | COM | 4.29M | SH | $67.34M 54.50% | 4.29M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 2.79M | SH | $17.11M 13.85% | 2.79M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 489.19K | SH | $16.24M 13.14% | 489.19K | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 3.81M | SH | $9.40M 7.61% | 3.81M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $6.04M 4.89% | 9.70M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM | 7.10M | SH | $3.82M 3.09% | 7.10M | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 1.20M | SH | $3.60M 2.91% | 1.20M | 0.00 | 0.00 |